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The intracellular protozoan parasite Theileria parva causes a lymphoproliferative disease of T cells in cattle
and uncontrolled lymphocyte proliferation in culture. We have identified and characterized in infected cells the
transcriptional activator, NF-KB, whose recognition motifs have been identified in several gene enhancers
important for lymphocyte-specific gene expression. NF-KB is normally constitutively activated in nuclear
extracts derived from B cells and can be induced in T cells and nonlymphoid cells by phorbol esters.
Theileria-infected lymphocytes contained constitutively high levels of activated NF-KB in nuclear fractions and
inactive NF-cB in cytoplasmic fractions. The inactive cytoplasmic precursor could be activated by treatment
of extracts with deoxycholate, which was shown previously to dissociate NF-KcB from an inhibitor, IKcB.
Treatment of lymphocyte extracts with 3 mM GTP stimulated NF-KB binding to its recognition motif in vitro,
thereby distinguishing it from a related nuclear factor, H2-TF1. Selective killing of the parasite, which left the
host cells intact, resulted in a rapid loss of NF-KB from the nuclear fractions and a slower loss from the
cytoplasmic fractions. In parasitized cells, NF-KcB could not be further stimulated by treatment with
12-0-tetradecanoylphorbol-13-acetate whereas in cells treated to remove the parasite, this compound stimu-
lated elevated levels of NF-KB. We propose that high levels of activated NF-KB are maintained by the presence
of the parasite in infected T cells. Similarly, we propose that the high levels of inactive cytoplasmic precursor
are a result of increased synthesis due to the presence of the parasite.
The intracellular protozoan parasite Theileria parva
causes a severe and usually fatal disease in cattle known as
East Coast fever. The disease is transmitted when infected
ticks, harboring infective sporozoites in their salivary
glands, take a bloodmeal on a susceptible animal. The
injected sporozoites invade lymphocytes and differentiate
into schizonts to form the pathogenic stage of the infection.
The parasite divides rapidly in the cytoplasm of the lympho-
cytes of the host and simultaneously induces a massive
lymphoproliferation which later in the disease is followed by
lymphocytolysis and death of the host (25, 32). The prolif-
erating lymphocytes gradually displace the normal lymphoid
tissue, resulting in a condition similar to a multicentric
lymphosarcoma (32). Infected lymphocytes, collected by
lymph node biopsy, carry T-cell surface markers and are
easily established in laboratory cultures as permanently
transformed lymphoblastoid cell lines (11, 29). Infected
lymphocytes can be grown in soft agar, form tumors in nude
mice, and can grow in culture with wholly artificial serum
supplements. Lymphocyte transformation is dependent on
the continuous presence of the parasite in the cytoplasm. A
unique and interesting feature of these cell cultures is that
their transformed phenotype can be reversed by selective
elimination of the parasite after drug treatment, leaving the
host cells viable but no longer proliferating (24). The revers-
ibility of cell transformation offers unusual opportunities in
the study of cell proliferation and transformation.
Our approach to understanding the parasite-induced pro-
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liferation has been to characterize gene expression in the
parasite as well as in infected lymphocytes. We would like to
determine what gene regulatory processes are influenced by
the presence of the parasite that result in uncontrolled cell
growth. We have previously described the constitutive
expression of interleukin-2 receptors (IL-2R) on the surface
of Theileria-infected T cells (14) and, along with others, have
suggested that proliferation may occur via an autocrine
mechanism whereby the cells produce and consume an
interleukinlike growth factor (12, 19).
Regulatory processes in gene expression, including IL-2R
gene expression, are mediated by interaction of trans-acting
protein factors of transcription that bind to cis-acting ele-
ments of gene enhancers (reviewed by Ptashne [36]). Some
of these transactivating factors, such as steroid receptors
and NF-KB, are themselves activated from preexisting pools
dormant in the cytoplasm (8, 30). Recently, the nuclear
factor NF-KB, crucial for expression of the kappa light-chain
immunoglobulin gene (41), has been shown to play a role in
the expression of the IL-2R(ot) chain as well as IL-2 during
activation of T lymphocytes (23, 28). NF-KB is important in
the activation of several other eucaryotic genes as well.
NF-KB-binding sequences are found in the human immuno-
deficiency virus (HIV) enhancer (33, 35), in the simian virus
40 enhancer (49), in the cytomegalovirus enhancer (10), and
upstream of the major histocompatibility complex class 1 (4,
48) and class 11 (9) genes. NF-KB-binding activity is consti-
tutively present in mature B cells and some T-cell lines and
can be induced in cells by lymphoid and nonlymphoid origin
by agents such as lipopolysacchandes, cycloheximide, phor-
bol esters, and DNA-damaging agents (40, 46). Furthermore,
the presence of a related nuclear factor, H2-TF1, which
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binds a sequence similar to NF-KB in lymphoid and nonlym-
phoid cells and also regulates MHC class I gene expression,
has been described (5).
The established regulatory properties of NF-KB in lym-
phoid cells and the potential role of this factor in constitutive
expression of the IL-2R gene in Theileria-infected T cells led
us to characterize the NF-KB-like proteins in parasite-in-
fected cells. We present data suggesting that the continuous
presence of the parasite in the cytoplasm of Theileria-
infected cells results in constitutively high levels of NF-KB
activity in the nucleus as well as high levels of the inactive
form in the cytoplasm.
MATERIALS AND METHODS
Cell lines and cultures. We used Theileria-infected bovine
T lymphocytes of the cloned cell line Tp(M)803 (20). Cul-
tures were grown at 37°C in Leibovitz L15 medium contain-
ing 10% heat-inactivated fetal bovine serum (GIBCO, Pais-
ley, Scotland), 20 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES) (pH 7.1), L-glutamine (20
,ug/ml), benzylpenicillin (100 U/ml), and streptomycin sulfate
(100 jig/ml). This medium is subsequently referred to as
cL15. Cells were initially seeded at 1.25 x 105/ml (day 0) and
grown in cL15 for different times. Cells were passaged on
day 4, when cell density was approximately 1.5 x 106/ml.
Elimination of the parasite from infected cells. The theile-
ricidal drug BW 720c is a hydronaphthoquinone derivative
with potent broad-spectrum antiprotozoal activity. BW
720c, a gift from Coopers Animal Health, Ltd., Berkham-
sted, United Kingdom, was used at a concentration of 50
ng/ml. The properties of this drug, which interferes with
parasite mitochondrial electron transport, have been de-
scribed elsewhere (24). The compound is not toxic for
mammalian cells even at concentrations much higher than
those used in this study.
ConA-stimulated lymphocytes. The isolation of bovine
lymphocytes and the generation of concanavalin A (ConA)-
stimulated lymphoblasts have been described previously
(31).
Plasmids. The two HIV-chloramphenicol acetyltransfer-
ase (CAT) plasmids used in this work are shown in Fig. 1.
Plasmid -121/+232 HIV-CAT contained the HIV type 1
(HIV-1) enhancer with two repeats of the KB elements and
the promoter region of the enhancer upstream of the bacte-
rial CAT gene in pBLCAT5. In -76/+232 HIV-CAT, the
region containing the KB motifs was deleted. The original
plasmids containing the HIV-1 long terminal repeat (LTR)
(33) were gifts of D. J. Capon. HIV sequences from these
plasmids were recloned into pBLCAT5 (46).
Plasmid pILCAT2/2+, containing two repeats of the 5'-
flanking region (-293 to -7) of the mouse IL-2 gene up-
stream of herpes simplex virus thymidine kinase promoter
(42), was a gift of E. Serfling. Plasmids pIL2R(at)CAT,
containing a part of the 5'-flanking region of the human
IL-2R(a) gene (-478 to +106) upstream of the CAT gene,
and pIL2R*(ot)CAT, a variant with four point mutations in
the NF-KB-binding site of this region (28), were a kind gift of
G. Nabel.
Cell transfection and CAT assays. Theileria-infected cells
growing in log phase were transfected by the DEAE-dextran
method (21, 37), with minor modifications. For each trans-
fection, 5 x 106 cells were pelleted gently, washed with
prewarmed TBS buffer (25 mM Tris hydrochloride [pH 7.4],
137 mM NaCl, 5 mM KCl, 0.6mM Na2HPO4, 0.7 mM CaCl2,
0.5 mM MgCl2) and suspended in 1.1 ml of DNA-TBS-
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FIG. 1. Structures of the HIV-CAT plasmids used to assay
KB-enhanced CAT transcription. Constructs: 1 and 2, -121/+232
HIV-CAT, containing DNA sequences from the HIV-1 LTR sur-
rounding the HIV RNA start (+1) placed upstream the bacterial
CAT gene; 3, -76/+232 HIV-CAT, containing a deletion in the
region of two KB repeats; 4, sequence of the first KB repeat from the
HIV enhancer; 5, mutated variant of no. 4; 6 and 7, pIL2R(os)CAT,
containing the human IL-2R(ot) gene upstream sequence with one
KB motif; 8, sequence of the mutated KB motif from plasmid
pIL2R*(a)CAT; 9, pILCAT2/2+, containing two repeats of the
5'-flanking region (-293 to -7) of the mouse IL-2 gene.
DEAE-dextran solution containing 10 ,ug of plasmid DNA
and 250 ,ug of DEAE-dextran (Pharmacia, Uppsala, Sweden)
per ml. The cell suspension was incubated at 37°C for 30
min. The cells were then treated with 10% dimethyl sulfox-
ide for 3 min, washed twice with prewarmed TBS, sus-
pended in 20 ml of cL15, and transferred to tissue culture
flasks. In some experiments, cells were treated approxi-
mately 26 h after transfection with 50 or 100 ng of 12-0-
tetradecanoyl phorbol-13-acetate (TPA) (Sigma Chemical
Co., St. Louis, Mo.), 5 ,ug of ConA per ml, or both. In all
cases, cells were harvested approximately 44 h after trans-
fection. Cell extracts containing 400 ,ug of total protein were
assayed for CAT activity. Quantitation of CAT assays was
performed by liquid scintillation counting of the appropriate
area from chromatography plates (22).
Purification and labeling of oligonucleotides. Oligonucleo-
tides were synthesized on a Pharmacia gene assembler and
purified for full-length product on a 20% polyacrylamide-8 M
urea gel. Oligonucleotides were end labeled with [-y-32P]ATP
and T4 polynucleotide kinase (30).
Preparation of nuclear and cytosol extracts and electropho-
retic mobility shift assay (EMSA). Nuclear and cytosolic
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extracts were prepared as described by Dignam et al. (18)
from cultures containing 2 x 108 cells incubated either in
medium alone or in medium with TPA (50 ng/ml) or BW 720c
(50 ng/ml). The binding reactions were carried out by incu-
bating end-labeled DNA (20,000 cpm) with 0.8 to 6 ,ug of
nuclear or cytosolic protein and 2 ,ug of poly(dI-dC) in a
buffer containing 10 mM HEPES (pH 7.9), 60 mM KCI, 4%
Ficoll, 1 mM dithiothreitol, and 1 mM EDTA (7). After 30
min at room temperature, the reaction mixtures were loaded
onto a 4% polyacrylamide gel in 0.25x TBE buffer (89 mM
Tris, 89 mM boric acid, 2 mM EDTA) and electrophoresed at
10 V/cm for 2 h at room temperature. For competition
experiments, a 200-fold molar excess of cold oligonucleotide
was added to the reaction mixture before the addition of
labeled DNA.
Treatment of cytosol fractions with the dissociating agent
0.6% sodium deoxycholate (DOC) in the presence of 1.2%
Nonidet P-40 (NP-40) was performed during the binding
reaction as described by Baeuerle and Baltimore (2).
RESULTS
The KcB motif of the HIV-1 enhancer mediates high-level
transcription of the CAT gene transfected into Theileria-
infected bovine T lymphocytes. To probe for the presence of
trans-acting factors that are activated by the parasite, we
transfected into Theileria-infected lymphocytes chimeric
plasmids containing different regulatory regions of the HIV
LTR, of the IL-2R(a) gene, and of the IL-2 gene (Fig. 1).
Each of these controlling regions was coupled to the reporter
CAT gene. Plasmid -121/+232 HIV-CAT (Fig. 1, no. 1)
contained both repeats of the NF-KB-binding sequence;
-76/+232 HIV-CAT (Fig. 1, no. 3) had the two KB se-
quences deleted. Plasmid -121/+232 HIV-CAT showed a
much higher basal level of CAT expression than did the
KB-deleted plasmid, -76/+232 HIV-CAT (Fig. 2A; compare
lanes 1 and 7). Levels of expression directed by the KB
sequences were increased 10- to 16-fold in separate trans-
fection experiments. Similar increased levels ofCAT expres-
sion were directed by plasmid pIL2R(a)CAT, containing the
KB motif, in comparison with CAT expression in cells
transfected with pIL2R*(a)CAT, which contained the mu-
tated KB-site and thereby interfered with NF-KB binding
(Fig. 2C, lanes 23 and 28). These results show that Theileria-
infected bovine T lymphocytes contained trans-acting fac-
tors that specifically enhanced CAT transcription via the
NF-KB-binding sequences from the HIV LTR or the IL-
2R(a) gene promoter regions.
T-cell lines have been shown to respond to activators such
as ConA and the phorbol ester TPA. Studies have shown
that these agents operate along fairly well defined signal
transduction pathways leading to the activation of calcium
mobilization and of protein kinase C. Antigenic and mitoge-
nic activation of T cells results in the induction of T-cell
growth factors and their receptors via activation of transac-
tivating factors of transcription, leading to cell proliferation
(15; reviewed by Isakov et al. [26]). Mitogen-activated
transcription in T cells can be blocked by cyclosporin A
(CsA) (44). To characterize the regulatory pathways utilized
by T. parva that lead to cell proliferation, we measured the
response of infected lymphocytes to these growth modifiers.
The effects of TPA, ConA, and CsA on CAT expression
directed by the HIV enhancer as well as by the IL-2R(a)
promoter region were tested in Theileria-infected cells trans-
fected with these plasmids.
TPA tested at two concentrations, 50 and 100 ng/ml, had
no effect on stimulating increased CAT activity directed by
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FIG. 2. (A) CAT activity directed by HIV-CAT plasmids in
bovine T lymphocytes infected by T. parva. Infected lymphocytes
were transfected with the HIV-CAT plasmids depicted in Fig. 1 by
using DEAE-dextran and maintained for 44 h before extracts were
prepared. TPA (50 or 100 ng/ml) and CsA (1 ,ug/ml) were added 16 h
before harvesting. CAT activity was measured by determining the
amount of acetylated chloramphenicol produced from [14C]chloram-
phenicol that separated on thin-layer chromatographs. The cell were
transfected by plasmids -121/+232 HIV-CAT (lanes 1 to 6) and
-76/+232 HIV-CAT (lanes 7 to 12). Cells were either not treated
(lanes 1 and 7) or treated with TPA at 50 (lanes 2 and 8) or 100 (lanes
3 and 9) ng/ml, with CsA (lanes 4 and 10), with TPA (50 ng/ml) plus
CsA (lanes 5 and 11), or with TPA (100 ng/ml) plus CsA (lanes 6 and
12). (B) CAT activity directed by HIV-CAT plasmids or pILCAT2/
2+. Theileria-infected lymphocytes were transfected with either of
two HIV-CAT plasmids or with pILCAT2/2+ (see Fig. 1). TPA (50
ng/ml) and ConA (5 ±Lg/ml) were added 16 h before harvest. Extracts
for CAT assays were prepared from cells transfected by plasmids
-121/+232 HIV-CAT (lanes 13 to 16), -76/+232 HIV-CAT (lanes
17 and 18), and pILCAT2/2+ (lanes 19 to 22). Cells were either not
treated (lanes 13, 17, and 19) or treated with TPA (lanes 14 and 20),
TPA plus ConA (lanes 15, 18, and 21), or ConA (lanes 16 and 22). (C)
CAT activity directed by pIL2R(a)CAT (lanes 23 to 27) and
pIL2R*(a)CAT (lanes 28 to 32). Cells were treated with TPA at 50
(lanes 24 and 30) or 100 (lanes 25, 31, and 32) ng/ml, CsA (lane 26),
or CsA plus TPA (50 ng/ml) (lane 27) or were untreated (lanes 23, 28,
and 29).
the HIV enhancer (Fig. 2A; compare lane 1 with lanes 2 and
3). CsA had no inhibitory effect on CAT activity when used
alone (lane 4) or together with TPA (compare lane 1 with
lane 4 and lane 4 with lanes 5 and 6). Treatment by ConA
also had no effect on the CAT activity in these cells whether
measured in the presence (Fig. 2B, lane 15) or absence (lane
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16) of TPA. Similarly, the basal level of CAT expression in
the KB-free plasmid did not change significantly after treat-
ment with TPA, CsA, or TPA plus CsA (lanes 7 to 12),
although it was slightly inhibited by TPA plus ConA (lane
18). The reasons for this inhibition by ConA are not clear.
Plasmid pIL2R(a)CAT, containing one KB motif in the 5'
regulatory region of the human IL-2R(a) gene, was weakly
induced after stimulation with 100 ng ofTPA per ml (Fig. 2C;
compare lanes 23 and 25). However, the increase in CAT
activity was perhaps independent of a functional KB site in
the enhancer because cells transfected with the mutated
variant, pIL2R*(a)CAT, also showed increased induction
with 50 ng ofTPA per ml (Fig. 2C; compare lanes 28 and 30).
The high ratio of induction (between 5- and 10-fold) was
caused by a low basal level of CAT transcription directed by
the construct with the mutated KB site (Fig. 2C; compare
lanes 23 and 28). The NF-KB-binding site of the IL-2R(oa)
enhancer appeared to mediate the high basal level of tran-
scription in Theileria-infected cells without TPA stimulation.
Under these conditions, TPA could not further augment
transcription. We conclude that in the absence of a func-
tional NF-KB site, the TPA inducibility of this gene depends
on the activation of other factors. CsA likewise had no
significant effect on CAT transcription mediated by the
controlling region of the IL-2R gene in this plasmid (Fig. 2C,
lanes 26 and 27).
Similarly, a plasmid containing two copies of the 5'
regulatory region of the mouse IL-2 gene (-293 to -7)
showed a slight but reproducible TPA induction of CAT
expression in Theileria-infected lymphocytes (Fig. 2B; com-
pare lanes 19 and 20). ConA did not increase the effect of
TPA (lane 21) and did not change the basal level of CAT
transcription directed by the regulatory region of the IL-2
gene (lane 22).
Consequently, both the IL-2 and IL-2R(a) gene regulatory
regions, unlike the HIV enhancer, could be induced by TPA
in Theileria-infected T cells, and this TPA inducibility was
independent of NF-KB-binding activity. To conclude, how-
ever, that factors other than NF-KB enhance the IL-2R gene
in response to TPA stimulation will require a more quanti-
tative analysis of this observation. NF-KB or an NF-KB-like
factor is fully activated in Theileria-infected cells and is not
further activated by TPA and ConA. CsA cannot block
because presumably there is no interference beyond the
activated transcription factors. It is possible that the parasite
directly activates NF-KB without influencing protein kinase
or the TPA pathway, unlike the situation in other T-cell lines
in which NF-KB activation is dependent on TPA treatment
(28, 47). There is as yet no direct proof for the involvement
of protein kinase C in activation of NF-KB or other trans-
acting factors.
Binding of nuclear proteins from extracts of Theileria-
infected T cells to the KB motif of the HIV enhancer. The
results of the functional studies described above focused our
attention on the KB sequence of the HIV enhancer. To
measure directly the level and location of NF-KB-like pro-
teins in T cells infected by T. parva, we used EMSA and two
different double-stranded oligonucleotides as radioactive
probes. The first oligonucleotide was the KB motif (repeat I)
of the HIV enhancer (Fig. 1, no. 4). The second oligonucle-
otide (mKB) contained three point mutations in the KB motif
(Fig. 1, no. 5). This mutation has been shown to enhance
neither transcriptional activity in transfected cells nor NF-
KB binding in vitro (34, 46). Incubation of the radiolabeled
KB oligonucleotide with nuclear extracts from Theileria-
infected T cells isolated on day 3 after passage produced two




FIG. 3. Presence and specificity of a factor binding to the KB-like
sequence from Theileria-infected T lymphocytes 3 days after seed-
ing. Shown are analyses of binding site specificity and competition
studies, using EMSA with the radiolabeled KB oligonucleotide from
the HIV-1 enhancer (lanes 1 to 5) or the mKB oligonucleotide (lanes
6 to 9). (These are the oligonucleotides depicted in Fig. 1, no. 4 and
5, respectively.) Nuclear extracts (4 ,ug of protein) from infected
lymphocytes (lanes 1 to 4 and 7 to 9) or from infected lymphocytes
treated with 50 ng of TPA per ml for 16 h (lanes 5 and 6) were
incubated alone or in the presence of unlabeled competitors, the KB
oligonucleotide (lanes 2, 6, and 9), or the mKB oligonucleotide (lanes
3 and 8). b2 and b3 are the two main retardation bands.
discrete, electrophoretically retarded DNA-protein com-
plexes (b2 and b3 in Fig. 3). The b2 complex was the major
component. Formation of these complexes was inhibited by
preincubation with a 200-fold molar excess of unlabeled KB
oligonucleotide but was not inhibited by the unlabeled mKB
oligonucleotide (Fig. 3, lanes 2 and 3, respectively). Treat-
ment of the cells with TPA for 16 h did not alter the EMSA
patterns (Fig. 3; compare lanes 4 and 5). Extracts from cells
treated for shorter times (30 min or 2 h) with TPA also did
not change the EMSA patterns (data not shown). As sug-
gested by results of the CAT experiments, it appears that
there was no effect of TPA on the activation of the
NF-KB-related proteins in T cells infected by the parasite.
Incubation of the radiolabeled mKB oligonucleotide with
nuclear extracts from Theileria-infected cells did not pro-
duce any significant DNA-protein complexes (Fig. 3, lanes 6
to 9). This experiment clearly shows the presence and
specificity of NF-KB-related proteins in extracts from bovine
T cells infected with the parasite T. parva.
In vitro activation of KB motif-specific DNA-binding pro-
teins in cytoplasmic extracts. In pre-B cells and nonlymphoid
cells, NF-KB is activated posttranslationally (40). NF-KB
resides in the cytoplasm in an inactive form. Treatment of a
cytosolic extract with 0.6% DOC in the presence of 1.2%
NP-40 leads to the dissociation of the complex NF-KB and its
cytoplasmic inhibitor IKB (2, 3). We used this technique to
look for the presence of a cytoplasmic precursor of NF-KB in
Theileria-infected T cells. Treatment of cytoplasmic extracts
from Theileria-infected cells with these detergents resulted
in a large increase in the observable binding of protein to the
KB oligonucleotide (Fig. 4; compare bands bO and bl in lanes
4 and 5 and in lanes 6 and 7). It is interesting that ConA-
stimulated bovine lymphocytes contained a large amount of
NF-KB-related proteins in the cytosol that also produced two
DNA-protein bands, bO and bl, in EMSA. Treatment of
cytosolic extracts from these cells with detergents slightly
increased their binding to the KB oligonucleotide (Fig. 4;
compare lanes 1 and 2). DOC and NP-40 together had no
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FIG. 4. Effects of dissociating agents on the binding of NF-KB
from cytosolic (c) and nuclear (n) fractions of bovine T lymphocytes
infected by T. parva or stimulated by ConA. Cell-free activation of
an NF-KB precursor was prepared by treatment with (+) or without
(-) 0.6% DOC in the presence of 1.2% NP-40. The DNA-binding
reactions were performed in the presence of 2 Lg of poly(dI-dC) and
2.5 ±g of protein from cytosol or nuclear extracts. The subcellular
fractions used for EMSA were the cytosolic fraction of ConA-
stimulated lymphocytes (lanes 1 and 2), the cytosolic fraction of
Theileria-infected lymphocytes prepared 3 days after passage (lanes
4 and 5), the same fractions prepared 5 days after passage (lanes 6
and 7), nuclear extracts from ConA-stimulated lymphocytes (lanes 3
and 8), nuclear extracts prepared on day 1 after passage from
Theileria-infected lymphocytes (lanes 9 and 10), and the same
extracts prepared on day 1 after passage (lanes 11 and 12). bO, bl,
and b2 are the three main retardation bands.
additional effect on binding to the DNA probes of nuclear
proteins from extracts of ConA-stimulated lymphocytes or
from extracts of Theileria-infected lymphocytes that were
prepared on day 1 after passage. These nuclear extracts
produced a major common band, bl, and different minor
bands, bO in ConA-stimulated lymphocytes and b2 in Theil-
eria-infected cells (Fig. 4; compare lanes 3 and 8 and lanes 9
and 10).
The NF-KB-like factor was fully activated in nuclei of
these cells, since the intensity of band bl did not increase
after DOC treatment. Unlike the case with ConA-stimulated
lymphocytes, activation by DOC of nuclear extracts pre-
pared 3 days after seeding of Theileria-infected cells in vitro
had a noticeable effect on the pattern of NF-KB binding to its
recognition sequence (Fig. 4, lanes 11 and 12). The intensity
of the minor band, bl, was consistently increased by DOC.
Band bl was also produced by nuclear extracts isolated on
day 1 after seeding, although no effect by DOC was ob-
served. This finding suggests that the appearance of a
DOC-sensitive band in the nuclei prepared on day 3 was
probably not due to systematic contamination from a DOC-
sensitive complex in the cytoplasm. The intensity of the
major band, b2, was variable after DOC treatment in dif-
ferent EMSA experiments, possibly because of the sensitiv-
ity to small differences in DOC concentration during treat-
ment of the extracts. Thus, there was an appreciable amount
of inactivated NF-KB present in nuclear extracts from Theil-
eria-infected cells beginning from day 3 after passage that
could be reactivated by detergent treatment.
Figure 5 shows the results of EMSA experiments measur-
ing the specificity of protein complexes that bound the
NF-KB oligonucleotide motif. All of the extracts tested
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FIG. 5. Specificity of NF-KB binding for cytoplasmic and nuclear
extracts from Theileria-infected bovine lymphocytes and extracts
from ConA-stimulated lymphocytes. Subcellular fractions were
analyzed by EMSA. Each assay consisted of 2.5 p.g of protein from
nuclear (n) or cytoplasmic (c) extracts (except for lane 6; see below)
incubated with the radiolabeled KB oligonucleotide preincubated in
the presence (+) or absence (-) of a 200-fold molar excess of
unlabeled KB oligonucleotide. Lanes: 1 to 3, cytoplasmic extracts
from ConA-stimulated lymphocytes; 4 to 6, cytoplasmic extracts
prepared on day 3 after seeding from Theileria-infected lympho-
cytes; 6, same as lane 5 but with 0.8 instead of 2.5 j±g of protein; 7
to 9, nuclear extracts from ConA-stimulated lymphocytes; 10 and
11, nuclear extracts prepared from Theileria-infected cells on day 1
after seeding.
contained proteins that bound to NF-KB sequences. Cyto-
plasmic extracts from ConA-stimulated cells (Fig. 5, lane 1
compared with lanes 2 and 3), nuclear extracts from the
same cells (lane 7 compared with lanes 8 and 9), and extracts
from Theileria-infected lymphocytes (lane 4 compared with
lanes 5 and 6 as well as lane 10 compared with lane 11)
produced bands in EMSA that could be abolished by excess
cold KB oligonucleotides. Formation of the bound com-
plexes could not be prevented by addition of excess nonra-
dioactive mutated oligonucleotide (data not shown).
An NF-KB-related factor has been shown to be induced in
HeLa cells after treatment with TPA (41). We compared the
binding properties of extracts from HeLa cells and bovine
lymphocytes. Extracts of TPA-treated HeLa cells produced
a DNA-protein complex, bO, that was similar to the main
band from ConA-stimulated lymphocytes (Fig. 6, lanes 1 and
3). On the other hand, a more complex set of band retarda-
tions was produced with extracts of Theileria-infected T
lymphocytes. This observation suggests the existence of
different forms of NF-KB. There was a difference in the
EMSA band patter of nuclear extracts from Theileria-
infected cells that depended on the age of the culture after
seeding. The difference may reflect a change in the rate of
culture growth. One band, bl, was characteristic of nuclear
extracts prepared on day 1 after passage, whereas two
bands, bl and b2, were observed in extracts prepared 3 days
after passage (Fig. 6, lanes 4 and 5). Hence, the EMSA
experiments with extracts from Theileria-infected lympho-
cytes revealed three main DNA-protein complexes that
resulted from binding of the NF-KB-like protein to its recog-
nition site. Bands bO through b3 from Theileria-infected cell
extracts have been shown to comigrate in a consistent
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FIG. 6. Comparison of the band shift patterns of NF-KB from
bovine lymphocytes and HeLa cells. For details of EMSA, see the
legend to Fig. 4. Extracts of HeLa cells induced by TPA for 3 h
contained 5 ,ug of protein per assay in the absence (lane 1) or
presence (lane 2) of a 200-fold molar excess of unlabeled competitor.
Cytosolic extracts of ConA-stimulated lymphocytes (lane 3) and
nuclear extracts prepared 1 and 3 days after passage of Theileria-
infected lymphocytes (lanes 4 and 5) contained 2.5 ,ug of protein per
assay. bO, bl, and b2 are the main retardation bands.
bands varied under different experimental conditions. We
could not distinguish in these experiments whether the
different bands resulted from different proteins binding to the
oligonucleotide or whether one protein produced multiple
bands due to different states of modification.
The data presented above support the proposal that Theil-
eria-infected cells contain substantial amounts of NF-KB-
like proteins in their nuclei and precursors of these proteins
in their cytoplasm. The data also suggest that some NF-KB
can be bound in a DOC-sensitive complex in the nuclei. The
cytoplasmic components bO and bl became more evident
after treatment with detergents that dissociated the precur-
sor-inhibitor complex. However, a small amount of band bO
could be seen without detergent treatment, especially in
Theileria-infected cells left to grow for 5 days without
passage (Fig. 4, lanes 6 and 7). The release ofNF-KB from its
inhibitor appeared to operate at the maximal rate, since no
further increase in NF-KB binding of nuclear extracts from
TPA-treated cells could be detected. The phorbol ester-
induced signal transduction pathway to other transcription
factors, however, still functioned, which suggests that T.
parva does not utilize the TPA pathway observed in other
cells (28). Alternatively, the existence of a large pool of the
cytoplasmic precursor of NF-KB suggests that the limiting
step in the activation of NF-KB may be the association of
NF-KB with other factors in the nucleus or possibly an
additional modification of NF-KB in the nucleus. It is possi-
ble that these processes are controlled by T. parva. It is also
clear from these data that there is an excess of NF-KB
synthesis in parasite-infected lymphocytes, resulting in an
abundance of the cytoplasmic precursor. The excess synthe-
sis and abundance of NF-KB in infected lymphocytes is in
sharp contrast to levels found in pre-B or non-B cells.
GTP-stimulated binding of NF-K.B from Theileria-infected
cells to the KB motif of the HIV enhancer. GTP has been
shown to substantially stimulate the binding of purified
NF-KB to its recognition sequence. This property has been
used to distinguish purified NF-KB from a closely related
nuclear factor, H2-TF1, whose binding is not influenced by
GTP even though the factor binds a DNA sequence motif
very similar to KB (5, 27). We tested the influence of GTP on
extracts from lymphocytes to determine whether Theileria-
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FIG. 7. Nucleoside triphosphate stimulation of NF-KB binding to
the NF-KB recognition sequence. Each lane shows the DNA-protein
complex formed with (+) or without (-) 3 mM GTP. Cytosolic (c)
and nuclear (n) extracts treated in vitro with 0.6% DOC contained
0.8 jig of protein per reaction. Lanes: 1 and 2, cytosolic extracts
from ConA-stimulated lymphocytes; 3 and 4, nuclear extracts
prepared on day 1 after passage from Theileria-infected lympho-
cytes; 5 and 6, cytosolic extracts prepared on day 5 after passage
from Theileria-infected lymphocytes. bO and bl are the main retar-
dation bands.
infected lymphocytes express an NF-KB with properties
similar to those of purified NF-KB. Treatment of nuclear and
cytoplasmic fractions with Theileria-infected lymphocytes
with 3 mM GTP strongly increased the DNA-binding prop-
erties of the cellular extracts for bands bO and bl (Fig. 7,
lanes 3 to 6). However, GTP treatment was not able to
change the DNA-binding properties of extracts from ConA-
stimulated lymphocytes (lanes 1 and 2). These data support
the idea that the NF-KB-like proteins observed in Theileria-
infected cells (bands bO and bl) are similar to purified
NF-KB. The presence of protein complexes not influenced
by GTP may suggest the existence of NF-KB proteins or
related proteins with different state of modification.
Changes in NF-KB-binding activity after elimination of the
parasite. Having established that Theileria-infected lympho-
cytes constitutively express and activate NF-KB, we at-
tempted to determine for what length of time the stimulatory
effect of the parasite remained after removal of the parasite
by drug treatment. By treating the Theileria-infected cells
with the drug BW 720c, which selectively kills the parasite,
leaving the host cell intact, we could determine the fate of
activated NF-KB. The effect of BW 720c on the growth of
Theileria-infected cells has been described earlier (19). Cell
growth and rates of [3H]thymidine incorporation during the
first 4 days of drug treatment remained approximately the
same in both drug-treated and untreated cell cultures. After
passage, however, the drug-treated cultures stopped grow-
ing. Only in the presence of added IL-2 will the drug-treated
cells grow for an additional 4 to 7 days (19).
Infected lymphocytes were treated with the drug at vari-
ous times, and nuclear extracts were prepared for testing in
EMSA. We used DOC treatment of nuclear extracts to
estimate the total amount of NF-KB (activated as well as
released from the inhibitor complex). The amount of NF-KB
in Theileria-infected lymphocytes varied with time after
passage (Fig. 8A, lanes 1 to 3). Levels of the factor remained
maximal for actively growing cells 1 day after seeding and
dropped three- to fourfold by days 3 and 5. On day 5, cells
were close to stationary growth phase (Fig. 8A, lanes 1 to 3).
Upon treatment with the drug BW 720c, a marked loss over
time of NF-KB binding in nuclear extracts were observed
MOL. CELL. BIOL.
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FIG. 8. (A) Influence of the theilericidal drug BW 720c and
changes in NF-KB binding from nuclear extracts isolated at different
time points during the growth of Theileria-infected cell cultures.
Nuclear extracts from Theileria-infected T cells (lanes 1 to 9) and
from ConA-stimulated lymphocytes (lane 10) were used for EMSA
with the radiolabeled KB oligonucleotide. Cells were initially seeded
at 1.25 x 105/ml (day 0) and grown in cL15 containing no additives
(lanes 1 to 3) or BW 720c (lanes 4 to 9) for the indicated times.
Cultures were passed on day 4. Cell density on day 4 was approx-
imately 1.5 x 106/ml; on day 5, the density of the nonpassaged
culture was 1.7 x 106 cells per ml. Cells treated with BW 720c and
recombinant IL-2 continued to divide after passage for 7 to 9 days
and were harvested at that time (lane 9). (B) Changes in the level of
the NF-KB precursor in the cytosolic fraction after drug treatment.
Bovine lymphocytes stimulated by ConA were used as positive
controls in absence (lanes 2 and 3) or presence (lane 1) of the
competitor, the unlabeled KB oligonucleotide. Theileria-infected
cells were grown with (lanes 8 to 11) and without (lanes 4 to 7) the
drug BW 720c. Extracts were prepared at the indicated times after
passage. Two protein concentrations were used in the DNA-binding
reactions: 2.5 (lanes 1 to 3, 5, 7, 9, and 11) and 1.2 (lanes 4, 6, 8, and
10) ,ug per reaction mixture.
(Fig. 8A, lanes 4 to 9). A decrease of NF-KB binding was
evident at 18 h after drug addition (lane 4); binding was
substantially reduced after 3 days of treatment (compare
lanes 7 and 2) and was barely detectable thereafter (lane 8).
Cells treated with the drug failed to grow further after
passage on day 4 and had nearly undetectable levels of
NF-KB at that time. Cells allowed to continue dividing in the
presence of IL-2 for 7 to 9 days also lost detectable levels of
NF-KB (lane 9). The loss of NF-KB closely paralleled the
previously documented loss of the parasite (19) as well as the
loss of parasite-specific transcripts (data not shown). It also
paralleled the reduction in proliferation. Loss ofNF-KB from
the cytoplasmic fractions after drug treatment can be seen in
Fig. 8B (lanes 4 to 11). Loss from the cytoplasm occurred to
a lesser extent than from nucleus. The losses were maximal
for extracts isolated from cells 3 days after drug treatment
A 'I
FIG. 9. Influence of TPA on levels of NF-KB in extracts from
infected and cured lymphocytes. Theileria-infected T-cell cultures
were seeded at 105 cells per ml and grown for 3 days before
preparation of nuclear extracts (lane 1). At 12 h before harvest, a
portion of the culture was treated with 50 nM TPA (lane 2). For
removal of the parasite, cultures were seeded at 5 x 104 cells per ml
and grown in the presence ofBW 720c for 5 days before preparation
of nuclear extracts (lane 3). At 12 h before harvest, a portion of the
drug-treated culture was treated with 50 nM TPA (lane 4). EMSA gel
analysis was performed as for Fig. 8, using 4 ,ug of protein in the
binding reactions.
(lanes 8 and 9) but were less for extracts isolated at 5 days
(lanes 10 and 11). The observed increase ofNF-KB precursor
binding from extracts isolated 5 days after drug treatment
over the level observed for extracts isolated after only 3 days
of treatment could possibly be explained if the synthesis of
NF-KB were maintained for a longer period than was the
parasite-stimulated activation ofNF-KB from its cytoplasmic
precursor.
As a comparative control for the loss of NF-KB from
treated lymphocytes, extracts from infected and drug-
treated lymphocytes were tested in EMSA for proteins that
bind the TATTTA box motif. We observed no change in the
amounts of TATTTA motif-binding proteins either as a
result of different culture growth conditions or as a result of
changes after drug treatment (data not shown). It appears,
therefore, that killing of the parasite by the drug BW 720c
specifically decreased NF-KB binding in nuclear fractions
and at the same time decreased the size of the cytoplasmic
precursor pool. We conclude that the presence of T. parva
not only activates NF-KB but also increases the synthesis of
NF-KB such that an excess of precursor is maintained in the
cytoplasm.
Elimination of the parasite restores NF-cB responsiveness to
TPA. To extend our observation in parasitized cells that
CAT activity under the control of NF-KB promoters in the
HIV-1 LTR does not respond to stimulation by TPA, and
having shown that the levels of NF-KB drop rapidly after
removal of the parasite by drug treatment, we decided to test
the TPA responsiveness of NF-KB in cured cells. Figure 9
represents an EMSA test showing the results of treating
T-cell cultures with TPA in the presence or absence of the
parasite. The results shown in lanes 1 and 2 support our
conclusion from the results in Fig. 2 that TPA had no
observable effect on the levels of NF-KB in infected cells.
The result in lane 3 demonstrates once again that upon loss
of the parasite by drug treatment, the levels of NF-KB
1 2 3 4 -5 6 7
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dropped very substantially. In addition, TPA treatment of
cells grown in the presence of the theilericidal drug BW 720c
to remove the parasite resulted in activation of NF-KB (lane
4). Thus, NF-KB levels became elevated in response to TPA
treatment only after removal of the parasite. This result
demonstrates that the presence of the parasite directly or
indirectly prevents the NF-KB response to TPA. The lack of
response in parasitized cells could have resulted from the
fact that NF-KB was being maximally activated or that the
parasite fed into a step intermediate in phorbol ester trans-
duction, e.g., between protein kinase C and activation of
cytoplasmic precursor of NF-KB. These possibilities are now
being investigated.
DISCUSSION
Infection of bovine T cells with the parasite T. parva
produces immortalized cell cultures that maintain character-
istics of transformed cancer cells. A detailed molecular
analysis of the host-parasite relationship should allow the
identification of important control processes used by the
host and possibly modified or interrupted by the parasite that
result in uncontrolled cell proliferation. We show here that
one of the effects resulting from the presence of the parasite
either directly or indirectly is the constitutive activation of
the trans-acting factor NF-KB. We show that the factor is
localized unevenly in both nuclear and cytoplasmic frac-
tions. The nuclear form is activated, whereas the cytoplas-
mic form is bound to an inhibitor. The NF-KB-like proteins
in infected lymphocytes differ from those in ConA-stimu-
lated lymphocytes and HeLa cells because the GTP-stimu-
lated binding of the protein to the NF-KB motif is found only
in parasitized cells, similar to the binding reported for
purified NF-KB (27). We cannot distinguish in these experi-
ments whether ConA-stimulated lymphocytes and Theileria-
infected lymphocytes have different NF-KB-like proteins or
the same proteins in different states of modification. We
show that only in infected cells can the cytoplasmic precur-
sor-inhibitor complex be activated by DOC in vitro. This
treatment has no significant effect on the factor in cytosol of
ConA-stimulated lymphocytes.
Although treatment with TPA and ConA does not result in
increased binding of NF-KB to the KB motif of the HIV-1
LTR and does not change KB-dependent transcription, TPA
does have some stimulating effect on CAT expression under
the control of 5'-flanking regions from the mouse IL-2 and
human IL-2R genes. It appears that the mild stimulatory
effect on the IL-2R(a) regulatory region is not related to
NF-KB binding, because plasmid pIL-2R*(at)CAT, contain-
ing a mutated KB sequence, is stimulated to a greater degree.
A more analytical analysis of this observation is required to
confirm and understand the factors that may activate tran-
scription. It is likely that in the IL-2 gene regulatory region
(-293 to -7), TPA-activated binding of the nuclear factor
AP-1 plays a role in IL-2 enhancer function (42). Theileria-
infected lymphocytes express constitutively high levels of
activated NF-KB in the nucleus. The high levels of inhibitor-
bound precursor in the cytoplasm must result from increased
synthesis of the factor in these parasitized cells. TPA treat-
ment does not alter the NF-KB levels in these cells and does
not increase KB-enhanced transcription, unlike the case with
other T-cell lines in which NF-KB activation was found to be
dependent on TPA treatment (28, 47). Stimulation of NF-KB
by TPA treatment does, however, reappear upon removal of
the parasite with drugs. This finding suggests that the signal
transduction pathway is not altered permanently by the
parasite.
There are several possibilities for the origin of the stimu-
lation that results in constitutive activation of NF-KB in
Theileria-infected lymphocytes. It has been postulated for
some trans-acting factors, and is most probable in the case of
NF-KB, that activation of the factors themselves occurs by
way of a posttranslation modification of the factors (2).
Activation of NF-KB in infected lymphocytes might simply
occur from the action of a protein from the parasite, similar
to the action of the Tax protein (previously named tat I gene
product) of human T-cell leukemia virus. Indeed, human T
cells transformed by this virus are characterized by perma-
nent expression of the IL-2R(a) gene, and transcription of
this gene depends on NF-KB activation by the Tax protein
(6, 16, 17, 28, 45). Similarly, several other cases of activation
of NF-KB protein by way of virus infection have been
described: activation by hepatitis B virus protein X (43), by
herpes simplex virus type 1 ICPO protein, and by adenovirus
protein ElA (35). One mechanism for activation of NF-KB
could be as a result of alterations of the inhibitor, IKB, such
as may occur during differentiation of pre-B cells into B cells
(3). The existence of a large pool of the cytoplasmic precur-
sor NF-KB in Theileria-infected cells that was not activated
by TPA treatment suggests that the limiting step of the
activation of NF-KB is either the modifying step operating at
the maximal rate or a step following the dissociation from its
inhibitor, e.g., the subsequent association of this factor with
other nuclear factors or possibly additional modifications of
NF-KB in the nucleus. Once the parasite is killed, the level of
active NF-KB drops dramatically and the inducibility ofTPA
reappears. This finding shows that the signal transduction
pathway has not been altered permanently by the parasite.
An important precedent for associations with multiple nu-
clear factors exists in the interaction of AP-1, the c-jun gene
product, with the c-Fos protein, which results in the gener-
ation of an active AP-1-site binding complex (13, 38, 39).
Preliminary evidence for the association of NF-KB with the
Fos protein has been obtained (B. Stein and V. Ivanov,
unpublished observations).
NF-KB is a trans-acting protein active in several eucary-
otic enhancer regions containing the KB motif, such as
the immunoglobulin kappa-chain gene enhancer (40), the
IL-2R(a) gene promoter region (28), and possibly the IL-2
gene promoter region, which also contains motifs for other
trans-acting factors (27, 42). Activation of the cytoplasmic
precursor of NF-KB and subsequent binding of the protein to
the KB motif in the regulatory regions are the necessary
stages for expression of these genes. The constitutive
expression of the IL-2R(a) gene in Theileria-infected lym-
phocytes (14, 19) could result from such an activation by
NF-KB.
A question that remains unresolved is the influence of the
parasite that results in increased NF-KB precursor synthesis.
We have clearly observed a decrease in the size of the
cytoplasmic NF-KB precursor pool as a result of parasite
elimination by treatment with the drug BW 720c. This finding
could be indirect evidence of the influence of the parasite on
the synthesis of the NF-KB precursor or possibly parasite-
mediated changes in its stability. Direct data on the influence
of the parasite on NF-KB gene transcription can be measured
only after cloning and sequencing of the NF-KB gene. A
reasonable speculation would be that activated NF-KB reg-
ulates its own expression, as has been shown for AP-1
transcription factor (1).
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